Kim G.P. Hoek

699 total citations
15 papers, 535 citations indexed

About

Kim G.P. Hoek is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Kim G.P. Hoek has authored 15 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Kim G.P. Hoek's work include Tuberculosis Research and Epidemiology (11 papers), Mycobacterium research and diagnosis (10 papers) and Infectious Diseases and Tuberculosis (6 papers). Kim G.P. Hoek is often cited by papers focused on Tuberculosis Research and Epidemiology (11 papers), Mycobacterium research and diagnosis (10 papers) and Infectious Diseases and Tuberculosis (6 papers). Kim G.P. Hoek collaborates with scholars based in South Africa, Australia and United States. Kim G.P. Hoek's co-authors include Robin M. Warren, Paul D. van Helden, Ben J. Marais, Nicolaas C. Gey van Pittius, Thomas C. Victor, T. C. Victor, Colleen A. Wright, Elizabeth M. Streicher, Mark P. Nicol and Rachael K. Jacobson and has published in prestigious journals such as Journal of Clinical Microbiology, Emerging infectious diseases and Archives of Disease in Childhood.

In The Last Decade

Kim G.P. Hoek

15 papers receiving 520 citations

Peers

Countries citing papers authored by Kim G.P. Hoek

Since Specialization

Citations

This map shows the geographic impact of Kim G.P. Hoek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim G.P. Hoek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim G.P. Hoek more than expected).

Fields of papers citing papers by Kim G.P. Hoek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim G.P. Hoek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim G.P. Hoek. The network helps show where Kim G.P. Hoek may publish in the future.

Co-authorship network of co-authors of Kim G.P. Hoek

This figure shows the co-authorship network connecting the top 25 collaborators of Kim G.P. Hoek. A scholar is included among the top collaborators of Kim G.P. Hoek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim G.P. Hoek. Kim G.P. Hoek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Neoehrlichiosis in Symptomatic Immunocompetent Child, South Africa 2023 ·Emerging infectious diseases ·Colleen Bamford, Lucille Blumberg, (unknown), John Frean, Kim G.P. Hoek, (unknown), Charlotte Sriruttan, Ilse Vorster, Marinda C. Oosthuizen	3
2	Molecular characterization of Staphylococcus aureus isolates from various healthcare institutions in Nairobi, Kenya: a cross sectional study 2016 ·Annals of Clinical Microbiology and Antimicrobials ·Geoffrey Omuse, (unknown), Kim G.P. Hoek, Shima M. Abdulgader, Samuel Kariuki, Andrew Whitelaw, Gunturu Revathi	31
3	Biofilm formation in invasive Staphylococcus aureus isolates is associated with the clonal lineage 2015 ·Microbial Pathogenesis ·Preneshni Naicker, (unknown), Kim G.P. Hoek, Justin Harvey, E Wasserman	37
4	Improved diagnosis of childhood tuberculous meningitis using more than one nucleic acid amplification test 2014 ·The International Journal of Tuberculosis and Lung Disease ·Regan Solomons, Douwe H. Visser, Sven O. Friedrich, Andreas H. Diacon, Kim G.P. Hoek, Ben J. Marais, J. F. Schoeman, A. Marceline van Furth	37
5	Commercial nucleic acid amplification tests in tuberculous meningitis—a meta-analysis 2014 ·Diagnostic Microbiology and Infectious Disease ·Regan Solomons, Sabine van Elsland, Douwe H. Visser, Kim G.P. Hoek, Ben J. Marais, Johan F. Schoeman, A. Marceline van Furth	25
6	Tuberculosis assays: past, present and future 2011 ·Expert Review of Anti-infective Therapy ·Novel N. Chegou, Kim G.P. Hoek, Magdalena Kriel, Robin M. Warren, Thomas C. Victor, Gerhard Walzl	50
7	Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa 2011 ·Infection Genetics and Evolution ·Elizabeth M. Streicher, Borna Müller, Violet Chihota, Charmaine Khudzie Mlambo, (unknown), Manormoney Pillay, André Trollip, Kim G.P. Hoek, Frederick A. Sirgel, Nicolaas C. Gey van Pittius, Paul D. van Helden, Thomas C. Victor, Robin M. Warren	62
8	Detecting Drug-Resistant Tuberculosis 2011 ·Molecular Diagnosis & Therapy ·Kim G.P. Hoek, Annelies Van Rie, Paul D. van Helden, Robin M. Warren, Thomas C. Victor	16
9	Xpert MTB/RIF for Rapid Diagnosis of Tuberculous Lymphadenitis from Fine-Needle-Aspiration Biopsy Specimens 2011 ·Journal of Clinical Microbiology ·(unknown), Mark P. Nicol, Kim G.P. Hoek, Rachael K. Jacobson, Paul D. van Helden, Ben J. Marais, Robin M. Warren, Colleen A. Wright	87
10	inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa? 2011 ·PubMed ·Borna Müller, Elizabeth M. Streicher, Kim G.P. Hoek, (unknown), André Trollip, M Bosman, Gerrit Coetzee, (unknown), E. Hoosain, Nicolaas C. Gey van Pittius, T. C. Victor, Paul D. van Helden, Robin M. Warren	62
11	Mycobacterial transport medium for routine culture of fine needle aspiration biopsies 2009 ·Archives of Disease in Childhood ·Colleen A. Wright, Colleen Bamford, (unknown), (unknown), Kim G.P. Hoek, Ben J. Marais, Robin M. Warren	7
12	Combining fine‐needle aspiration biopsy (FNAB) and high‐resolution melt analysis to reduce diagnostic delay in mycobacterial lymphadenitis 2009 ·Diagnostic Cytopathology ·Colleen A. Wright, Kim G.P. Hoek, Ben J. Marais, Paul D. van Helden, Robin M. Warren	9
13	Resistance to pyrazinamide and ethambutol compromises MDR/XDR-TB treatment. 2009 ·PubMed ·Kim G.P. Hoek, H. Simon Schaaf, Nicolaas C. Gey van Pittius, Paul D. van Helden, Robin M. Warren	20
14	Discordance between Mycobacterial Interspersed Repetitive-Unit-Variable-Number Tandem-Repeat Typing and IS6110Restriction Fragment Length Polymorphism Genotyping for Analysis ofMycobacterium tuberculosisBeijing Strains in a Setting of High Incidence of Tuberculosis 2008 ·Journal of Clinical Microbiology ·M. Hanekom, Gian van der Spuy, Nicolaas C. Gey van Pittius, Christopher R. McEvoy, Kim G.P. Hoek, S. L. Ndabambi, A. Jordaan, T. C. Victor, Paul D. van Helden, Robin M. Warren	53
15	Fluorometric Assay for Testing Rifampin Susceptibility of Mycobacterium tuberculosis Complex 2008 ·Journal of Clinical Microbiology ·Kim G.P. Hoek, Nicolaas C. Gey van Pittius, (unknown), (unknown), A. Jordaan, Gian van der Spuy, Elizabeth M. Streicher, T. C. Victor, Paul D. van Helden, Robin M. Warren	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact